Accelerating Life-Saving Therapies: How Precision Medical Group Transformed Clinical Data With Maia, the AI Data Automation Platform
TL;DR
Precision Medicine Group (PMG) initially used Matillion to centralize and harmonize siloed data from over 20 acquisitions. But their lean team still faced a roadblock: manual workflows for pipeline maintenance and 40,000 daily schema variations were slowing progress toward AI.
By evolving to Maia – the AI Data Automation platform – PMG now automates repetitive engineering tasks, adapts pipelines at scale, and enforces governance.
This shift cut pipeline understanding from two days to 30 minutes and is accelerating delivery of trusted data for drug development.
Driving Therapies With Trusted, Productive Data
PMG’s mission is clear: deliver life-changing therapies for oncology and rare disease patients. Every day, the stakes are high: the speed at which clinical trials are set up, patients are recruited, and drug data is analyzed directly impacts patient lives. Every second matters.
At the center of this mission is PMG’s data team, led by Roberto Lara, VP of Digital Transformation and Analytics, and Ammad Baig, Director of Data and AI Services. With deep experience in clinical development and data services, they understand that accelerating and standardizing data isn’t just a matter of efficiency – it can accelerate drug delivery to patients who need it most.
The Long Road to Harmonized Data
PMG has grown rapidly, acquiring over 20 companies since 2011. This created a sprawling landscape of silos, inconsistencies, and incompatible schemas – a serious vulnerability in a regulated environment where data must be trustworthy enough to support FDA submissions
One of our biggest challenges was the need for standardized, structured, and harmonized data – data we could ultimately leverage and, most importantly, trust.” Roberto explains.
In 2021, PMG committed to a major strategic shift: to centralize all core enterprise systems into a unified data lake and warehouse with comprehensive governance.
Matillion became the foundation for this transformation. The interoperability between Matillion’s ETL platform and Snowflake provided PMG's lean team with:
The AI Roadblock: When Manual Work Stops Innovation
Despite this foundational success, the PMG engineering team was still wrestling with relentless manual workflows. The lean team, while highly skilled, was stretched thin, spending too much time on repetitive tasks and core development work.
This was a huge roadblock to PMG’s ambitious future plans. “There is no AI strategy without a data strategy,” Roberto states.
With the team stuck fighting schema drift, maintaining pipelines, and writing documentation, they couldn’t focus on building a governed semantic layer – critical for clinical AI, advanced analytics, and regulatory confidence.
This meant PMG was ready for the next evolution: Maia.
The Agentic Shift: Automated, Governed Data Management the 'PMG Way'
Maia, Matillion’s AI Data Automation platform, became the catalyst for accelerating PMG’s mission.
Using Maia’s Context Engine, PMG captured its engineering standards - naming conventions, SOPs, quality checks, and pipeline patterns - so Maia can generate workflows exactly the way their engineers would, only faster and with consistent governance baked in. Every pipeline aligns with PMG’s clinical and regulatory requirements from day one, reducing the manual reviews that once slowed delivery.
Maia also transformed how PMG manages constant schema drift across global studies. By reading metadata, sampling warehouse tables, and adjusting or regenerating pipelines based on PMG’s rules, Maia resolves issues that used to take hours in minutes – and documents every change automatically.
Ammad believes the agentic framework is the only way forward, noting that moving from sequential to simultaneous workloads handled by AI will deliver results much more quickly.
“The agentic framework is allowing our engineers to be more strategic and focus on domain expertise while delegating repetitive tasks to our framework.”
The Freedom to Accelerate Life-Saving Therapies
For Roberto, the ultimate measure of success is the speed and accuracy of the data being delivered:
"Our ability to generate accurate and trustworthy data is meaningful because the results that are being generated – leveraging Maia – are being used to drive approvals for drugs and the new compounds that are being then offered to patients looking for cures.”
The partnership between Precision Medicine Group and Matillion is moving the organization toward its goal of accelerating drug development, ensuring that data engineering is no longer a bottleneck, but a catalyst for life-changing therapies.
From Days to Minutes: The Human Impact
Data management
made effortless
